Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Patricia K Coyle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
EFC17504 A Randomized Double-blind Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis
Coyle, P. K. (PI), Kowalska, A. (CoPI), Polito, K. (CoPI), McLinskey, N. (CoPI) & Melville, P. (CoPI)
Sanofi US Services Incorporated
04/9/24 → 10/25/26
Project: Research
-
An Interventional, Phase 3 Extension Study to Investigate Long-Term Safety and Tolerability of Tolebrutinib in Participants with Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis of Nonrelapsing Secondary Progressive Mult
Coyle, P. K. (PI), Kowalska, A. (CoPI), McLinskey, N. (CoPI) & Melville, P. (CoPI)
Sanofi US Services Incorporated
03/12/24 → 10/25/26
Project: Research
-
IQVIA RDS: A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab in Patients with Multiple Sclerosis
Coyle, P. K. (PI), McLinskey, N. (CoPI), Melville, P. (CoPI) & Syritsyna, O. (CoPI)
06/6/22 → 01/21/27
Project: Research
-
SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Neuromyelitis Optica Spectrum Disorder Registry (NMOSD-750)
Coyle, P. K. (PI), Polito, K. (CoPI), McLinskey, N. (CoPI) & Melville, P. (CoPI)
04/22/22 → 01/23/27
Project: Research
-
Genentech: A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
Coyle, P. K. (PI), Kowalska, A. (CoPI), McLinskey, N. (CoPI), Melville, P. (CoPI) & Syritsyna, O. (CoPI)
06/1/21 → 01/6/27
Project: Research
-
Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses
Arnaboldi, P. M., Becker, J., Nath, A., Coyle, P. K., Handel, A., Sellati, T. J., Gomes-Solecki, M., Garcet, S., Henderson, M. K., Mullins, P., Cowan, E., McCombie, W. R., Wellins, A. M., Allegretta, M., Bergquist, J. & Schutzer, S. E., Jun 3 2026, In: Brain. 149, 6, p. 1842-1859 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Impact of sex on multiple sclerosis therapy
Coyle, P. K., Jul 2025, In: Neurotherapeutics. 22, 4, e00620.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Special Edition: Therapeutic advances in multiple sclerosis
Coyle, P. K., Jul 2025, In: Neurotherapeutics. 22, 4, e00697.Research output: Contribution to journal › Editorial
Open Access -
Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium
the New York State Multiple Sclerosis Consortium (NYSMSC), Feb 2024, In: Journal of Neurology. 271, 2, p. 711-722 12 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
How Do I Approach the Evaluation and Treatment of Early Lyme Disease?
Schutzer, S. E. & Coyle, P. K., Aug 2024, In: NEJM Evidence. 3, 8Research output: Contribution to journal › Article › peer-review
2 Scopus citations